MSD
Pembrolizumab
Biodrugs/ Drugs
Cancer
"Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell
Carcinoma (LA HNSCC)"
3Phase III in Spain,
2Phase II,
1Phase I